Life Science Reagents Market Growth Drivers and Restrain Factors Study Report

Life Science Reagents Market Outlook 2031
The global life science reagents market was valued at US$ 54.7 Bn in 2021
The global market is projected to grow at a CAGR of 5.7% from 2022 to 2031
The global life science reagents market is expected to reach more than US$ 100 Bn by the end of 2031

Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1162

Overview of Life Science Reagents Market
Life science reagents are substances or compounds used in a chemical reaction to observe and record changes. Medical researchers analyze this data to determine the cause of a disease. Life science and analytical reagents are used in chemical reactions to measure, detect, or examine other substances. Technological advancements in molecular biology, life sciences, and biotechnology have brought about significant changes in health care diagnostics, drug discovery, personalized medicines, forensic sciences, and clinical research & development. This has increased the demand for biotechnology media, sera and reagents, biotechnology reagents, etc. Growth of the life science industry and increase in incidence rate of chronic and infectious diseases are driving the global life science reagents market.

Increase in Geriatric Population and Rise in Need for Disease Diagnosis Propel Global Life Science Reagents Market
Advances in the health care industry and life sciences industry, improvement in public health measures, and decrease in life-threatening infectious diseases in developed countries are augmenting the life expectancy of the global geriatric population. According to the United Nations, the elderly population (aged 60+ years) is expected to double by 2050 and triple by 2100. The population is likely to rise from 962 million in 2017 to 2.1 billion in 2050 and 3.1 billion in 2100. Globally, the geriatric population is growing at a faster rate than the young population. The geriatric population in Asia Pacific and South America is estimated to increase by 300% in the next decade. As part of preventive health care, the geriatric population and people with chronic diseases such as diabetes, respiratory disorders, and cancer regularly require medical tests such as blood tests and urine tests. This is projected to augment the life science reagents market during the forecast period.

Enquiry before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1162

Rise in Adoption of Advanced Products to Drive Global Life Science Reagents Market

Development in the areas of enzyme-linked immune assay technology (ELISA), polymerase chain reaction (PCR) such as digital PCR, rtPCR, chromatography, single cell technology, next-generation sequencing (NGS), and flow cytometry techniques; and their application in the health care industry in disease diagnostics and treatment monitoring are propelling the life science reagents market. For instance, the chemiluminescence immunoassay (CLIA) technology provides enhanced sensitivity, specificity, improved precision, and reduced incubation. Together, these increase the efficiency of the technology to diagnose different types of genetic, chronic, acute, and infectious diseases. Technological advancements in point-of-care (POC) instruments for the diagnosis of various chronic and infectious diseases within a short period, development of high throughput automated immunoassay analyzers, and integration of the various diagnostic techniques in a single system are factors fueling the demand for in vitro diagnostics reagents in the health care industry. Advances in genomics and proteomics have led to the development of newer genetic and protein biomarkers for the diagnosis of cancer and several genetic diseases. Genomic studies are also used in pharmacogenetics and targeted therapy to identify infectious diseases by sequencing reagents to diagnose genetic factors that contribute to common diseases and personalized medicines. Increase in application of cell and tissue culture for the production of monoclonal antibodies, drug development, vaccines, enzymes, growth hormones, and stem cell therapy is propelling the demand for life science reagents.

Get Custom Research Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1162

Growth in Prevalence of Chronic and Infectious Diseases to Augment Global Life Science Reagents Market

Diagnosis of infectious and chronic diseases is one of the leading applications of in vitro diagnostics. Life science reagents, both biological and laboratory chemical reagents, are integral part of any diagnostic test. Emergence and outbreak of various infectious diseases have created challenges and new opportunities for researchers to develop life science tools and reagents for early diagnosis and prevention of disease. As of June 2022, coronavirus (COVID-19) has caused 539 million confirmed infections and 6.3 million deaths. The pandemic does not show any sign of abatement. The impact and consequences of the COVID-19 pandemic positively impacted the life science reagents market in 2020 and 2021. Growth of the diagnostics segment, led by Covid-19 testing and continuous research & development conducted by various pharmaceutical & biotechnological companies to develop medicines and vaccines, is likely to drive the life science reagents market during the forecast period.

Get Report Methodology @ https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=1162

Popularity of Immunoassay as Diagnostic Tool to Drive Demand for Immunoassay Reagents

In terms of product, the global life science reagents market has been classified into chromatography reagents, molecular diagnostic reagents, immunoassay reagents, clinical chemistry reagents, flow cytometry reagents, cell & tissue culture reagents, hematology & hemostasis reagents, microbiology reagents, and others. The immunoassay reagents segment dominated the global life science reagents market in 2021. The trend is projected to continue during the forecast period. Immunoassay is a highly preferred diagnostic technique used in hospitals and pathology laboratories. The immunoassay technique is increasingly becoming a popular diagnostic tool owing to specific results, high sensitivity, and ease of use.

High Usage of Life Science Reagents to Propel Hospitals & Diagnostics Laboratories Segment
Based on end-user, the global life science reagents market has been divided into hospitals & diagnostic laboratories, commercial & contract research manufacturers, academic & research institutes, and others. The hospitals & diagnostic laboratories segment dominated the global life science reagents market in 2021 due to the high usage of life science reagents in hospitals and laboratories for the diagnosis of Covid-19.

Read Report Overview @ https://www.transparencymarketresearch.com/life-sciences-reagents-analytical-reagents.html

Analysis of Key Players in Global Life Science Reagents Market
The global life science reagents market is fragmented, with the presence of a large number of key players. Most companies are making significant investments in research & development activities. Expansion of product portfolios and mergers & acquisitions are the key strategies adopted by the players. Key players operating in the market include F. Hoffmann-La Roche AG, Danaher Corporation, Abbott, Siemens Healthineers, DiaSorin S.p.A, Sysmex Corporation, bioMerieux SA, Thermo Fisher Scientific, Inc., BD, Merck KGaA, Agilent Technologies, Inc., and Waters Corporation.

Key Developments in Global Life Science Reagents Market
In January 2022, Beckman Coulter Life Sciences announced that it received the EU Quality Management System Certificate under the new In Vitro Diagnostic Medical Devices Regulation (IVDR) for more than 200 flow cytometry reagents developed and manufactured at its Marseille, France, facility

In December 2021, Thermo Fisher Scientific, Inc. acquired PeproTech, Inc., a U.S.-based developer and manufacturer of recombinant proteins, for US$ 1.86 Bn in net cash. PeproTech provides bioscience reagents known as recombinant proteins, including cytokines and growth factors.

In January 2021, Thermo Fisher Scientific, Inc. acquired the Belgium-based European viral vector manufacturing business of Groupe Novasep SAS for US$ 830 Mn in net cash consideration. It provides manufacturing services for vaccines and therapies to biotechnology companies and large biopharma customers.
Each of these players has been profiled in the life science reagents market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

This release was published on openPR.